Anti‐CD20 monoclonal antibody therapy in postpartum women with neurological conditions

OBJECTIVE: Postpartum, patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) have increased risk for disease activity. Anti‐CD20 IgG1 monoclonal antibodies (mAb) are increasingly used as disease‐modifying therapies (DMTs). Patients may wish to both breastfeed and r...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Annika, Rowles, William, Poole, Shane, Balan, Ayushi, Bevan, Carolyn, Brandstadter, Rachel, Ciplea, Andrea I., Cooper, Joanna, Fabian, Michelle, Hale, Thomas W., Jacobs, Dina, Kakara, Mihir, Krysko, Kristen M., Longbrake, Erin E., Marcus, Jacqueline, Repovic, Pavle, Riley, Claire S., Romeo, Andrew R., Rutatangwa, Alice, West, Timothy, Hellwig, Kerstin, LaHue, Sara C., Bove, Riley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647007/
https://www.ncbi.nlm.nih.gov/pubmed/37675826
http://dx.doi.org/10.1002/acn3.51893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647007/
https://www.ncbi.nlm.nih.gov/pubmed/37675826
http://dx.doi.org/10.1002/acn3.51893

Ejemplares similares